Cell Source, Inc. is a biotechnology company, which focuses on developing cell therapy treatments based on the management of immune tolerance. The company is headquartered in New York City, New York. The company went IPO on 2014-01-14. The firm is primarily focused on the development of immune system management technology (Veto Cell technology). Its lead prospective product is its Veto Cell immune system management technology. Its Veto Cell technology is an immune tolerance biotechnology that enables the selective blocking of immune responses. Its Veto Cell technology is in pre-clinical phase, and its data shows that it provides results in allogeneic (donor-derived) hematopoietic stem cell transplantation (HSCT) by allowing for haploidentical stem cell transplants under a mild conditioning regimen. Its product pipeline includes chimeric antigen receptor (CAR) T-cell therapies, which include VETO CAR-T (with or without HSCT) for B-cell malignancies, Veto Cell kidney transplants, VETO CAR-T for solid tumors, Veto Cell liver transplants, and Veto HSCT for non-malignant disorders. The firm's wholly owned subsidiary is Cell Source Limited (CSL).
CLCS stock price ended at $0.84 on Vendredi, after rising 10.53%
On the latest trading day Jan 16, 2026, the stock price of CLCS rose by 10.53%, climbing from $0.76 to $0.84. Throughout the session, the stock experienced a volatility of 30.26%, with prices fluctuating between a daily low of $0.76 and a high of $0.99. Alongside this price increase, trading volume also rose by 23.9K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 23.4K shares were traded, amounting to a market value of approximately $33.6M.
Signaux Techniques de CLCS
Résumé des Signaux Techniques
Acheter des signaux 5
Signaux neutres 0
Signaux de vente 2
Strong Sell
Sell
Neutral
Buy
Strong Buy
CLCS présente actuellement 5 signaux d'achat et 2 signaux de vente. L'action est en tendance haussière depuis 12:00 AM, avec une variation totale du prix de 40% pendant cette période. En général, les indicateurs techniques indiquent une tendance Buy à moyen terme.
Signaux haussiers/baissiers pour CLCS
Nous analysons les indicateurs clés comme les moyennes mobiles, le RSI, le MACD et le volume de transactions pour générer des signaux haussiers et baissiers pour CLCS, vous aidant à prendre des décisions d'investissement éclairées.
Questions complémentaires
Comment les indicateurs d'analyse technique s'appliquent-ils à CLCS ?
Quels sont les niveaux de retracement de Fibonacci pour CLCS ?
Quel est le RSI de Cell Source Inc ?
Quel est le prix de Cell Source Inc pour les 12 prochains mois ?